Comparing Pharmacologic Measures of Tenofovir Exposure in a U.S. Pre-Exposure Prophylaxis Randomized Trial

PLoS ONE - United States
doi 10.1371/journal.pone.0190118
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Tenofovir-Based Pre-Exposure Prophylaxis for HIV Prevention

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2012English

Strong Relationship Between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)

PLoS ONE
Multidisciplinary
2014English

HIV Pre-Exposure Prophylaxis

CMAJ
Medicine
2014English

Probenecid‐Boosted Tenofovir: A PBPK Model Informed Strategy for On‐demand HIV Pre‐exposure Prophylaxis

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2019English

Routine Pre-Exposure Rabies Prophylaxis: A Reassessment.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1984English

The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2016English

Bone Mineral Density Changes Among HIV-Uninfected Young Adults in a Randomised Trial of Pre-Exposure Prophylaxis With Tenofovir-Emtricitabine or Placebo in Botswana

PLoS ONE
Multidisciplinary
2014English

Choosing a Metric for Measurement of Pre-Exposure Prophylaxis

The Lancet Infectious Diseases
Infectious Diseases
2014English

Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana

World Journal of AIDS
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy